The development of a GRPR-targeting imaging probe could improve the diagnosis of PCa with insufficient PSMA expression, while the use of the SPECT imaging modality could make this diagnostic procedure available to a wider patient population [16]. This evidence concerns the gene FOLH1 and posterior cortical atrophy.